Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia
Oncotarget (2016) - Comments
pubmed: 27494886  doi: 10.18632/oncotarget.10984  issn: 1949-2553 

Ayman A.M. Alameen, Carolina Simioni, Alberto M. Martelli, Giorgio Zauli, Simona Ultimo, James A. McCubrey, Arianna Gonelli, Giorgia Marisi, Paola Ulivi, Silvano Capitani, Luca M. Neri